C12.ai and Danaher Sign Strategic Partnership Agreement
C12.ai and Danaher signed a strategic partnership agreement at the Shenzhen Life Science Innovation Conference on September 19, 2026. The collaboration will expand opportunities to validate laboratory robots and apply them to real research workflows in the life sciences.
On September 19, 2026, C12.ai and Danaher signed a strategic partnership agreement at the 2026 Shenzhen Life Science Innovation Conference, held in Shenzhen under the theme “From Precision to Prediction.”
Representatives from both companies signing the agreement
For C12.ai, the agreement is an important step in developing its laboratory robotics business in the life sciences. Through its collaboration with Danaher, C12.ai will work more closely with real R&D needs, expand opportunities for product validation and practical applications, and strengthen collaboration with partners across the life sciences industry.
C12.ai and Danaher representatives at the signing ceremony
Building on this agreement, C12.ai will continue refining products and solutions for real research workflows, bringing AI and robotics to more life sciences R&D applications.
The robotics demonstration booth at the conference
About C12.ai
C12.ai focuses on applying large AI models and embodied intelligence to laboratory R&D. The company develops laboratory robots and intelligent solutions that connect molecular design with physical execution. Serving pharmaceutical R&D, life sciences, and fine chemicals, C12.ai helps scientists move from hypothesis to validation faster.
About Danaher
Danaher is a global innovator in life sciences and diagnostics, with businesses spanning biotechnology, life sciences, and diagnostics. Through scientific and technological innovation, Danaher works with customers to advance critical research and diagnostic work, address major global health challenges, and improve human health.